Polio vaccine trial

The randomised part of the Salk Polio Vaccine trial has all the hallmarks of modern day trials randomisation, control group, blinding and it was experiences of these kinds that helped convince researchers that only under these conditions can clear, scientifically valid conclusions be drawn. 

One of the largest trials ever conducted took place in the US in 1954 and concerned the evaluation of the Salk Polio Vaccine. The trial has been reported extensively by Meier (1978) and is used by Pocock (1983) in his discussion of the historical development of clinical trials. 

Wyeth ( 16 billion in sales). Formerly known as American Home Products, this company headquartered in Madison, New Jersey, makes many well-known OTC drugs such as Robitussin and Advil. The company first used machines to mass-produce tablet pills in 1872 and supplied the polio vaccine for early trials in the 1950s. It produced a diet drug called fenfluramine that when combined with other drugs into a form known as fen-phen caused health problems and was withdrawn from the market. It makes Premarin and Prem-pro for estrogen replacement, Effexor for depression and anxiety disorders, Ativan for anxiety and insomnia, and Enbrel for arthritis. 

On 1st February 1951 Flenrietta Lacks, who was suffering from cervical cancer, had - without her consent - samples of her cervix removed at the Johns Hopkins Hospital In Baltimore. She deceased on 4th October of the same year. A subset of her malignant cells was characterised and found to divide beyond the normal limit. From a single of these cells, researchers were able to establish the first Immortal human cell line, which they labelled HeLa-cells, in memory of the donor. From 1952 right up to the present time, this cell line is used worldwide for research purposes, as e.g. for the development of the polio vaccine by Jonas Salk at the University of Pittsburgh School of Medicine, which underwent clinical trials already in 1954. 

Sabin, who carried out much of his research at Ghildren s Hospital in Gincinnati, developed an attenuated version of the polio vaccine by the 1950 s. The initial large-scale trial of Sabin s vaccine, which involved more than 100 million people, was carried... 

The National Foundation, which funded the research, and the American public wanted a mass vaccination urgently. The average incidence of polio in the US in 1949-1953 was 25.7 cases per 100 000 children. The National Foundation ordered 27 million doses of the Salk vaccine for a trial, and close to one million children were vaccinated (749 236 children from Grades 1,2 and 3 were offered vaccine, and 401 974 completed the trial). 

---